Welcome to IHUB. AMBS shares in Todos is only a small part of the AMBS valuation story. Hope you find the below helpful.
List of indications AMBS assets may be able to treat (aka shots on goal):
Parkinson's Disease (PD)
Amyotrophic Lateral Sclerosis (ALS) - Lou Gehrig's Disease -
Ischemic Heart Disease
Alzheimer's Disease (AD)
Huntington's Disease
Traumatic Brain Injury/ Chronic Traumatic Encephalopathy (TBI/CTE)
ischaemic stroke
Bipolar Disorder
maintaining circadian plasticity of neurons
Umbilical Cord Mesenchymal Stem Cells for treating Spinal Cord Injury
Charcot-Marie-Tooth disease (CMT)
cancer immunotherapy
Retinitis Pigmentosa (RP); and,
other Inherited Retinal Disorders
Multiple Sclerosis Experimental autoimmune encephalomyelitis
Control of Energy Homeostasis
Liver Damage
Aging
Heart Attack
Bacterial Myocarditis
Age related macular degeration
MANF in Acetaminophen (APAP)-induced liver injury (AILI)
Glaucoma
Post-Operative Delirium via Inhibiting Inflammation and Microglia Activation
Sporadic Retinal Disorders
Other degenerative disorders and retinal injury
Wolfram's Syndrome
Diabetes Type-1
Diabetes Type-2
type 2 diabetes mellitus
Osteoarthritis,
Parabiosis
alcoholic pancreatitis
Diagnosis of Parkinson's Disease
Assays for diagnosis and therapeutics
47 Protein Biomarkers for Neurodegenerative Diseases
Assays for Amyotrophic Lateral Sclerosis (ALS) and ALS-like disorders
Diagnosis of Alzheimer's Disease
Alzheimer's Disease (AD)
TBI/CTE
Parkinson's Disease Levodopa Induced Dyskinesia (PD-LID)
Attention Deficit Hyperactivity Disorder (ADHD)
Lipidomics Assay
Exosoms Assay
Four additional Assays
Congenital Hairy Nevus
Type 3 and 4 intractable sever burns
MSPrecise Diagnostic for Multiple Sclerosis (MS)
Neurosarcoid Diagnostic Assay
Neuromeylitis optica Diagnostic Assay
Para neoplastic Disease Diagnostic Assay
Amyotrophic Lateral Sclerosis (ALS) Diognostic Assay
List of AMBS related IP:
Patent Subsidiary Owner Group Title
US20020182198A1 MANF Commissiong Dopaminergic neuronal survival-promoting factors and uses thereof
US20110212055A1/BRPI0909221A2 MANF Commissiong Neurodegenerative disorders
ES2353490T3 MANF Commissiong STIMULATION FACTORS OF DOPAMINERGICAL NEURONAL SURVIVAL AND ITS USES.
US20190060402A1 MANF Commissiong Method of enhancing dopaminergic neuronal cell growth or survival with manf
WO2011038366A1 MANF Commissiong Dopaminergic selective factors
WO2014066686A1 MANF Commissiong Brain targets for neurotrophic factors to treat neurodegenerative disease
US20170072015A1/EP3113788A1 MANF Commissiong Methods and compositions for the protection of sensory cells
US9115208B2 MANF Commissiong Dopaminergic neuronal survival-promoting factors and uses thereof
WO2009120810A2 MANF Commissiong Neurodegenerative disorders
CA2719582A1 MANF Commissiong Methods and compositions for treating parkinson's disease with manf
US20140371103A1 MANF Commissiong Methods and reagents for evaluating autoimmune disease and determining antibody repertoire
US20170274048A1 MANF Buck Methods and compositions for modulating the imune system
CA2973701A1 MANF Lowe Methods of treating motor and movement disorders and side effects thereof associated with parkinson's disease treatments
WO2012170918A2/CA2838818A1 MANF Wen Methods of treatment for retinal diseases
WO2016057579A1 MANF Urfer Methods and compositions for treating retinal disorders
EP2380024B1 MANF Roche Armet as a marker for cancer
WO2015200469A1 MANF Schwartz Manf as a regulator of immune system function
CA2725356C ELTO Psychogenics Use of eltoprazine for improving symptoms of cognitive impairment associated with non-adhd neurological and mental disorders
US20160341745A1 DIAG Commissiong Methods, Systems, and Composition Related to Neural Disorders CTE
CA3144876A1 DIAG Commissiong A biomarker for alzheimer's disease using blood samples from clinically diagnosed alzheimer's disease subjects
WO2016127113A1 DIAG Wilks Methods for diagnosing multiple sclerosis using vh4 antibody genes
US20100314251A1 DIAG Commissiong Diagnosis of Parkinson's disease
US20080289964A1 DIAG Commissiong Assays for diagnosis and therapeutics employing similarities and differences in blood serum concentrations of 3 forms of complement C3c and related protein biomarkers between amyotrophic lateral sclerosis and Parkinson's disease
"US20100294664A1
" DIAG Commissiong Assay for ALS and ALS-like disorders
US20110236917A1 DIAG Commissiong Diagnosis of Alzheimer's Disease
"WO2021161283A1
" Tollo Arad Compounds for treating coronavirus infection
"US20210378540A1
" Tollo Arad Physical methods for living tissue inactivation and detection, and physical methods in use for the detection and inactivation of living bodies (like ebola and 2019 coronavirus) in living systems and non-living systems thereof
WO2021156878A2 Tollo Arad Rapid detection test for sars-cov-2
US11129871B1 MANF Urano Compositions and methods for treating and preventing endoplasmic reticulum (ER) stress-mediated kidney diseases
WO2013112602A1/US10845371B2 MANF Urano Soluble manf in pancreatic beta-cell disorders
EP2753641A1 MANF Saarma Neuroprotective cell-penetrating peptides
FI20080326A0 MANF Saarma Neurotroofinen tekijä MANF ja sen käytöt
WO2018202957A1 MANF Saarma C-terminal cdnf and manf fragments, pharmaceutical compositions comprising same and uses thereof
WO2014191630A3 MANF Saarma Non-human animal model encoding a non-functional manf gene
CN109364249B MANF Anhui Application of MANF-targeted substance in preparation of product for treating intrahepatic bile duct cancer
CN112138146A MANF Anhui Application of MANF protein for Sicca syndrome
CN109675019A MANF Anhui The pharmaceutical usage of middle cerebro-cardiac apoplexy derived neurotrophic factor
CN112587654A MANF Anhui Application of mesencephalon astrocyte-derived neurotrophic factor in treatment of ulcerative colitis
CN110237238A MANF Shandong MANF is promoting the application in corneal injury reparation
CN110656087B MANF Zheijang MANF gene modified umbilical cord mesenchymal stem cell and preparation method and application thereof
AI
